| Stanmore Resources Limited (SMR) ORDINARY FULLY PAID |
Materials |
$2,353 |
2025 Half Year Financial Results Investor Presentation
|
25 Aug 2025 8:11AM |
$2.180 |
$2.610 |
risen by
19.72%
|
|
SMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from coal sales down 34% year-on-year.
- Average sales price reduced by 25%.
- Sales volumes declined by 436Kt compared to 1H 2024.
- Positive EBITDA margins maintained despite challenges.
- Net profit after tax turned negative due to lower EBITDA.
- Strong balance sheet with low net debt.
- Significant weather impacts on production plans.
- Continued deleveraging and shareholder returns.
- Production weighted towards second half recovery.
- Guidance reaffirmed for the full year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stanmore Resources Limited (SMR) ORDINARY FULLY PAID |
Materials |
$2,353 |
2025 Half Year Financial Results Investor Presentation
|
25 Aug 2025 8:11AM |
$2.180 |
$2.610 |
risen by
19.72%
|
|
SMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Net operating cash flow of US$115 million
- Capital expenditures of US$36 million
- Production recovery anticipated in the second half of 2025
- MRA2C Creek Diversion Project completed
- Isaac Downs Extension Project prioritized for development
- Available liquidity of US$401 million
- Strong balance sheet and continued shareholder returns
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stanmore Resources Limited (SMR) ORDINARY FULLY PAID |
Materials |
$2,353 |
2025 Half Year Results
|
25 Aug 2025 8:11AM |
$2.180 |
$2.610 |
risen by
19.72%
|
|
SMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Saleable coal production of 6.5 million tonnes and sales of 6.6 million tonnes.
- Total revenue from coal sales was US$867 million with an underlying EBITDA of US$147 million.
- 1H 2025 FOB cash costs were US$89/t, maintained within the full-year guidance range.
- Robust balance sheet with US$181 million total cash and US$99 million net debt.
- Completion of MRA2C creek diversion project supports expansion at South Walker Creek.
- Reserves increased to 534 million tonnes and resources to 5.1 billion tonnes.
- No interim dividend declared for 2025 due to macro-economic uncertainties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stanmore Resources Limited (SMR) ORDINARY FULLY PAID |
Materials |
$2,353 |
2025 Half Year Results
|
25 Aug 2025 8:11AM |
$2.180 |
$2.610 |
risen by
19.72%
|
|
SMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Solid 1H 2025 financial performance with US$867 million revenue from coal sales
- Underlying EBITDA of US$147 million
- Total coal sales of 6.6 million tonnes despite challenging weather conditions
- FOB cash costs of US$89/t within guidance range
- Robust balance sheet with US$181 million cash and US$99 million net debt
- Completion of large-scale projects ahead of schedule and under budget
- New reserves declared for Isaac Downs Extension Project
- No interim dividend declared for 2025 due to economic uncertainties
- Reaffirmed 2025 guidance with focus on increased production and cost control
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stanmore Resources Limited (SMR) ORDINARY FULLY PAID |
Materials |
$2,353 |
Appendix 4D and Interim Financial Report
|
25 Aug 2025 8:11AM |
$2.180 |
$2.610 |
risen by
19.72%
|
|
SMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss of $50.5 million for the half-year ending 30 June 2025.
- Decrease in cash and cash equivalents from $288.9 million to $181.2 million.
- Revenue decline and increased operating expenses.
- Significant depreciation and amortization charges.
- Total liabilities decreased from $1,372.2 million to $1,223.5 million.
- Provisions and liabilities showed adjustments mainly due to remeasurements.
- Net assets amounted to $1,718.0 million.
- Movements in property, plant, and equipment and capitalized development assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Stanmore Resources Limited (SMR) ORDINARY FULLY PAID |
Materials |
$2,353 |
Appendix 4D and Interim Financial Report
|
25 Aug 2025 8:11AM |
$2.180 |
$2.610 |
risen by
19.72%
|
|
SMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss after tax of $50.5 million for the half-year ended 30 June 2025.
- Revenue from coal sales decreased significantly due to lower prices and volumes.
- Cash inflows from operations fell to $150.6 million.
- Operating expenses decreased, partly due to cost-saving initiatives.
- Zero Serious Accident Frequency Rate achieved.
- Cash and cash equivalents at $181.2 million by end of June 2025.
- Ongoing decarbonisation initiatives include a Pongamia plantation.
- No interim dividend recommended by the Directors.
- No significant post-reporting events affecting operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NIB Holdings Limited (NHF) ORDINARY FULLY PAID |
Financials |
$3,618 |
2025 Group Climate-Related Disclosure
|
25 Aug 2025 8:11AM |
$7.710 |
$7.400 |
fallen by
4.02%
|
|
| Mount Hope Mining Limited (MHM) ORDINARY FULLY PAID |
Materials |
$10 |
Drilling Commences at Mt Hope Project
|
25 Aug 2025 8:11AM |
$0.170 |
$0.240 |
risen by
41.18%
|
|
| NIB Holdings Limited (NHF) ORDINARY FULLY PAID |
Financials |
$3,618 |
2025 Sustainability Report
|
25 Aug 2025 8:11AM |
$7.710 |
$7.400 |
fallen by
4.02%
|
|
| NIB Holdings Limited (NHF) ORDINARY FULLY PAID |
Financials |
$3,618 |
2025 Full Year Results Investor Presentation
|
25 Aug 2025 8:11AM |
$7.710 |
$7.400 |
fallen by
4.02%
|
|
NHF - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue growth driven by pricing increases.
- Claims inflation reached 21.0% in second half of FY25.
- Implementation of claims recovery action plan.
- Service cost inflation decreased to 6% in line with sector CPI.
- Completion of core system upgrades improved service levels.
- Launch of new life insurance product range in Q4 FY25.
- New Zealand insurance revenue increased by 8.1%.
- Underlying operating profit affected by high claims inflation.
- Net promoter scores improved across various segments.
- Investment in AI and digital initiatives for growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NIB Holdings Limited (NHF) ORDINARY FULLY PAID |
Financials |
$3,618 |
2025 Full Year Results ASX Announcement
|
25 Aug 2025 8:10AM |
$7.710 |
$7.400 |
fallen by
4.02%
|
|
NHF - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 group revenue increased to $3.6 billion, up 7.8% from FY24.
- Net profit after tax (NPAT) was $198.6 million, a 9.4% increase from FY24.
- Australian residents' health insurance achieved highest sales with 3.2% policyholder growth.
- NIB expanded services including dental networks and managed claims inflation effectively.
- International segment for students and workers saw a 23% increase in underlying operating profit.
- Fully franked dividend of 29.0 cents per share declared, matching FY24 payout.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NIB Holdings Limited (NHF) ORDINARY FULLY PAID |
Financials |
$3,618 |
2025 Full Year Results ASX Announcement
|
25 Aug 2025 8:10AM |
$7.710 |
$7.400 |
fallen by
4.02%
|
|
NHF - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue increased to $3.6 billion in FY25.
- Underlying operating profit was $239.2 million.
- Net profit after tax rose by 9.4% to $198.6 million.
- The highest ever sales were achieved in the Australian health insurance business.
- Policyholder growth was 3.2%, exceeding industry growth.
- The company faced claims inflation and economic challenges.
- NIB maintained a dividend of 29 cents per share.
- Strategic focus on core private health insurance and growth.
- Leveraging digital enhancements and AI for customer value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NIB Holdings Limited (NHF) ORDINARY FULLY PAID |
Financials |
$3,618 |
Appendix 4G and 2025 Corporate Governance Statement
|
25 Aug 2025 8:10AM |
$7.710 |
$7.400 |
fallen by
4.02%
|
|
| NIB Holdings Limited (NHF) ORDINARY FULLY PAID |
Financials |
$3,618 |
Dividend/Distribution - NHF
|
25 Aug 2025 8:10AM |
$7.710 |
$7.400 |
fallen by
4.02%
|
|
| Underwood Capital Limited (UWC) ORDINARY FULLY PAID |
Health Care |
$11 |
UWC FY25 Results Presentation
|
25 Aug 2025 8:10AM |
$0.050 |
$0.056 |
risen by
12%
|
|
| NIB Holdings Limited (NHF) ORDINARY FULLY PAID |
Financials |
$3,618 |
Appendix 4E and 2025 Annual Report
|
25 Aug 2025 8:10AM |
$7.710 |
$7.400 |
fallen by
4.02%
|
|
NHF - Price-sensitive ASX Announcement
Full Release
Key Points
- nib reported an underlying operating profit of $239.2 million and a net profit after tax of $198.6 million for FY25.
- Group revenue reached $3.6 billion, with a final dividend of 16 cents per share declared, totaling 29 cents for the year.
- Significant claims inflation occurred in Australian and New Zealand private health insurance businesses.
- nib achieved strong sales in its private health insurance business in Australia during FY25.
- The organization managed claims inflation to 4.9%, slightly affected by increased NSW Government charges.
- nib's Health Services division, including Honeysuckle Health, moved closer to profitability with a loss reduction to $7.0 million.
- The company completed the acquisition of the full ownership of Honeysuckle Health and Midnight Health.
- nib is focusing on integrating customer healthcare experiences through its Health Services division.
- Continued engagement in health management programs, with over 22,300 people enrolled to manage chronic conditions.
- The New Zealand business faced challenges due to high claims inflation and a soft economy.
- nib's capital management ensured a strong equity position and adherence to APRA standards.
- The Group's strategy involves expanding its digital and AI capabilities to enhance customer value.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NIB Holdings Limited (NHF) ORDINARY FULLY PAID |
Financials |
$3,618 |
Appendix 4E and 2025 Annual Report
|
25 Aug 2025 8:10AM |
$7.710 |
$7.400 |
fallen by
4.02%
|
|
NHF - Price-sensitive ASX Announcement
Full Release
Key Points
- Profit for the year ended 30 June 2025 is $198.6 million.
- Basic earnings per share increased to 41.1 cents.
- Acquisition of full ownership in Honeysuckle Health Pty Ltd.
- Increased investment in The ItsMy Group Pty Ltd.
- Declared interim and final dividends totaling 29 cents per share.
- Directors' declaration confirms compliance with accounting standards.
- Strategic focus on health insurance sector investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Waratah Minerals Limited (WTM) ORDINARY FULLY PAID |
Materials |
$221 |
Becoming a substantial holder
|
25 Aug 2025 8:10AM |
$0.660 |
$0.570 |
fallen by
13.64%
|
|
| Underwood Capital Limited (UWC) ORDINARY FULLY PAID |
Health Care |
$11 |
FY25 UWC Appendix 4E and Annual Report
|
25 Aug 2025 8:10AM |
$0.050 |
$0.056 |
risen by
12%
|
|
UWC - Price-sensitive ASX Announcement
Full Release
Key Points
- UWC reported strong financial results for FY25, with significant revenue growth compared to the prior year.
- The company operates in the engineering and manufacturing sector, focusing on high-precision parts and assemblies for various industries including semiconductor, life sciences, and others.
- Profit after tax increased, reflecting operational efficiencies, margin improvements, and effective cost controls.
- UWC continued investments in capacity expansion, automation, and R&D to drive future growth.
- The Board recommended a final dividend, highlighting the company’s commitment to shareholder returns.
- UWC’s balance sheet remains robust, with healthy cash reserves and low gearing.
- Outlook for FY26 is optimistic, underpinned by a strong order book, ongoing customer demand, and strategic investments.
- ESG (Environmental, Social, and Governance) initiatives remain a priority, with progress made in sustainability and corporate governance practices.
- The company disclosed remuneration practices for directors and key management personnel, aligning with performance and market benchmarks.
- No material litigation or contingent liabilities were reported during the period.
- The annual report includes detailed disclosures in line with ASX and international financial reporting standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Traka Resources Limited (TKL) ORDINARY FULLY PAID |
Materials |
- |
General Meeting - Notice of Access
|
25 Aug 2025 8:10AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Traka Resources Limited (TKL) ORDINARY FULLY PAID |
Materials |
- |
Notice of General Meeting/Proxy Form
|
25 Aug 2025 8:09AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| Vita Life Sciences Limited (VLS) ORDINARY FULLY PAID |
Health Care |
$141 |
Dividend/Distribution - VLS
|
25 Aug 2025 8:09AM |
$2.170 |
$2.600 |
risen by
19.82%
|
|
| Dyno Nobel Limited (DNL) ORDINARY FULLY PAID |
Materials |
$6,606 |
Update - Notification of buy-back - DNL
|
25 Aug 2025 8:09AM |
$3.120 |
$3.770 |
risen by
20.83%
|
|
| Nuix Limited (NXL) ORDINARY FULLY PAID |
Information Technology |
$507 |
FY25 Financial Results Presentation
|
25 Aug 2025 8:09AM |
$2.170 |
$1.490 |
fallen by
31.34%
|
|
NXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Nuix Limited delivered year-on-year revenue growth driven by increased recurring revenue streams.
- Strong demand for digital investigation and analytics solutions contributed to the positive financial outcomes.
- The company invested in expanding its product portfolio, including new features and integrations.
- Operational efficiencies and cost management were prioritized to improve margin performance.
- Nuix strengthened its governance framework and risk management processes.
- Strategic partnerships and customer engagement initiatives supported market expansion.
- Resolved or addressed several ongoing legal and regulatory matters.
- FY25 guidance indicates continued revenue growth, careful cost management, and focus on profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nuix Limited (NXL) ORDINARY FULLY PAID |
Information Technology |
$507 |
Nuix Announces FY25 Results
|
25 Aug 2025 8:09AM |
$2.170 |
$1.490 |
fallen by
31.34%
|
|
NXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Nuix announces FY25 guidance with strong anticipated growth in ACV and statutory revenue.
- ACV expected between $197m and $205m, reflecting 12.5%-17.2% growth.
- Statutory revenue forecasted at $205m-$215m, representing 11%-16.3% growth.
- Statutory EBITDA anticipated to be $48m-$55m.
- Growth to be driven by product innovation, sales and marketing investment, and customer engagement.
- Focus on expanding product portfolio and increasing recurring revenue.
- Strategic investments and disciplined capital allocation will support long-term growth.
- Continued focus on operational efficiencies while investing in future expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
